Last reviewed · How we verify

NCT01532739

Making Memory Better for Seniors With Mild Cognitive Impairment

Active, enrolled NA Last updated 21 August 2024
What this trial tests

NA trial testing Cognitive training in Mild Cognitive Impairment in 40 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
5 December 2011
Primary endpoint
5 December 2025
5 December 2025

Quick facts

Lead sponsorNova Scotia Health Authority
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposetreatment
Enrollment40
Start date5 December 2011
Primary completion5 December 2025
Estimated completion5 December 2025
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Nova Scotia Health Authority — full company profile →

Who can join

Eligibility, any sex, with Mild Cognitive Impairment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the feasibility and effectiveness of a cognitive training group in individuals with Mild Cognitive Impairment, using a new paradigm that will optimize ecological validity by (1) focusing on everyday memory problems, (2) supplementing traditional memory training with the teaching of an empirically-supported problem-solving approach, and (3) employing a clinically representative sample of individuals with MCI (e.g., not excluding those with mild affective symptoms).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Cognitive training

Trials testing the same drug.

Other recruiting trials for Mild Cognitive Impairment

Currently open trials in the same condition.

Other Nova Scotia Health Authority trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01532739.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing